Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02810171 · ClinicalTrials.gov registry record · NA

Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT02810171: Completed NA study, sponsored by University of Michigan.

NCT02810171 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02810171, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

Anxiety is among the most prevalent, costly and disabling illnesses and tends emerge early in childhood. Cognitive behavioral therapy (CBT) is the first-line treatment for early life anxiety, but as many as 40% of young patients who receive CBT fail to get better. The proposed study will examine brain changes marking positive response to CBT for anxiety and how these changes may differ in children compared adolescents. By helping us to understand how CBT works, this study will pave the way for new treatments to stop anxiety early.

Primary Outcome

Pre- to post-CBT changes in functional, connectivity and structural MRI measures of brain networks relevant for anxiety. Brain regions include the amygdala, anterior insula, dorsal anterior cingulate cortex (dACC) and ventrolateral prefrontal cortex (vlPFC). Functional activation and connectivity of these brain regions are assessed using simple computer tasks performed during MRI scanning. Tasks engage threat reactivity, self-regulatory control and the interaction of these processes. Structural

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Relaxation Therapy

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2016-12
Est. Completion 2021-11-12
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02810171 record still lists

NCT02810171 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT02810171 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02810171 about?

NCT02810171 is a clinical study titled "Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety". Anxiety is among the most prevalent, costly and disabling illnesses and tends emerge early in childhood. Cognitive behavioral therapy (CBT) is the first-line treatment for early life anxiety, but as many as 40% of young patients who receive CBT fail to get better. The proposed study will examine bra...

What is the current status of trial NCT02810171?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2016-12. Estimated completion is 2021-11-12.

What interventions are being tested in trial NCT02810171?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Relaxation Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02810171?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02810171's enrollment target sits among peer trials

207 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02810171, the US trial registry maintained by the National Library of Medicine. NCT02810171 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.